Literature DB >> 16546754

Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre.

Ashley S Shaw1, Mary-Ann Ampong, Alan Rio, Ammar Al-Chalabi, Maria E K Sellars, Catherine Ellis, Christopher E Shaw, Nigel P Leigh, Paul S Sidhu.   

Abstract

A retrospective review was carried out on the influence of pre-procedure respiratory assessment on survival of patients with amyotrophic lateral sclerosis (ALS) requiring nutritional support with either a gastrostomy or a nasogastric feeding tube. Over a five-year period 98 patients (49 male, 49 female; median age 61 years, range 26-86 years) with ALS were referred for enteral feeding with either radiological inserted gastrostomy (RIG), percutaneous endoscopic gastrostomy (PEG) or nasogastric tube (NG). Case notes review was performed to record patient age, sex, pre-procedure respiratory assessment, method of enteral feeding and survival post-procedure. Kaplan-Meier survival curves were constructed for each group, with Cox regression analyses performed in order to establish the effect of each variable on outcome. Median survival (with 95% confidence intervals) following RIG, PEG and NG was 6.31 months (4.58-8.04 months), 7.13 months (4.81-9.45 months) and 0.95 months (0.00-2.77 months), respectively. The survival advantage between RIG and PEG was not statistically significant (p = 0.50), but for NG versus RIG and PEG groups combined, there was a significant difference (p = 0.03). For patients with normal overnight oximetry, median survival was 8.54 months (3.88-13.21 months), compared to 4.80 months (1.20-8.39 months) in the abnormal oximetry group (p = 0.03; relative risk 1.97). It is concluded that RIG and PEG are equivalent in terms of post-procedure survival. Abnormal oximetry prior to the procedure is a significant indicator of post-procedure survival.

Entities:  

Mesh:

Year:  2006        PMID: 16546754     DOI: 10.1080/14660820510012013

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  16 in total

1.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 2.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis.

Authors:  Nazem Atassi; Merit E Cudkowicz; David A Schoenfeld
Journal:  Amyotroph Lateral Scler       Date:  2011-05-09

4.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

Review 5.  Nutrition and dietary supplements in motor neuron disease.

Authors:  Jeffrey Rosenfeld; Amy Ellis
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

Review 6.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 7.  Multidisciplinary Interventions in Motor Neuron Disease.

Authors:  U E Williams; E E Philip-Ephraim; S K Oparah
Journal:  J Neurodegener Dis       Date:  2014-11-18

8.  Percutaneous endoscopic gastrostomy versus fluoroscopic gastrostomy in amyotrophic lateral sclerosis (ALS) sufferers with nutritional impairment: A meta-analysis of current studies.

Authors:  Biying Yang; Xiaolei Shi
Journal:  Oncotarget       Date:  2017-11-06

9.  Mushroom-cage gastrostomy tube placement in patients with amyotrophic lateral sclerosis: a 5-year experience in 104 patients in a single institution.

Authors:  Dylan Lewis; Mary-Ann Ampong; Alan Rio; Emma Willey; Julia Johnson; Christopher E Shaw; Catherine M Ellis; Ammar Al-Chalabi; P Nigel Leigh; Paul S Sidhu
Journal:  Eur Radiol       Date:  2009-02-04       Impact factor: 5.315

10.  Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.

Authors:  Sonja Körner; Melanie Hendricks; Katja Kollewe; Antonia Zapf; Reinhard Dengler; Vincenzo Silani; Susanne Petri
Journal:  BMC Neurol       Date:  2013-07-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.